Phenotypic variation of dairy cows' hematic metabolites and feasibility of non-invasive monitoring of the metabolic status in the transition period

奶牛血液代谢物的表型变异及过渡期代谢状态无创监测的可行性

阅读:1

Abstract

INTRODUCTION: The incidence of metabolic diseases tends to be highest during the transition period (±3 weeks around parturition) in dairy cows due to physiological changes and the onset of lactation. Although blood profile testing allows for the monitoring of nutritional and metabolic status, conducting extensive analyses in the herd is costly and stressful for cows due to invasive procedures. Therefore, mid-infrared spectroscopy (MIR) could be seen as a valid alternative. METHODS: In the present study, we used laboratory-determined reference blood data and milk spectra of 349 Holstein cows to (i) identify the non-genetic factors affecting the variability of major blood traits in healthy cows and, subsequently, (ii) test the predictive ability of milk MIR. Cows belonged to 14 Italian commercial farms and were sampled once between 5 and 38 days in milk. For β-hydroxybutyrate (BHB), non-esterified fatty acids (NEFA), cholesterol, glucose, urea, total protein, albumin, globulin, minerals, aspartate aminotransferase, gamma-glutamyl transferase, creatine kinase, total bilirubin, and cortisol, the effects of parity, days in milk, and season were investigated using a linear model. RESULTS AND DISCUSSION: The results indicate that all fixed effects significantly affected the hematic concentration of most of the traits. Regarding MIR, the most predictable traits were BHB, NEFA, and urea, with coefficients of determination equal to 0.57, 0.62, and 0.89, respectively. These values suggest that MIR predictions of BHB and NEFA are not sufficiently accurate for precise and punctual determination of the hematic concentration, however, still the spectrum of the milk can be exploited to identify cows at risk of negative energy balance and subclinical ketosis. Finally, the predictions can be useful for herd screening, decision-making, and genetic evaluation.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。